Results of use to treat covid

This Hydroxychloroquine Which was suggested in hospitalized Covid patients during the first wave of the virus, despite a low level of evidence, may have caused about 17,000 premature deaths in the six countries analyzed in the scientific study. This has been revealed in a study collected by the magazine Biomedicine and Pharmacotherapy In which a team of French researchers has estimated Premature mortality associated with this treatment in six countries including Belgium, France and the United States.

During the first wave of Covid, treatment with hydroxychloroquine (HCQ) was used “off-label despite the absence of evidence documenting its clinical benefits,” the authors emphasized.

has been the aim of the researcherso Calculate the number of deaths caused For this treatment in countries where it was applied to hospitalized patients during the first two or three months of the epidemic.

The authors based their estimates on available data for six countries Number of patients No covid admitted to hospital In the first wave, patients who were treated and those whose deaths were attributed to it, among others.

Fear of using drugs with a low level of evidence

In the case of the study giving details BelgiumOf 19,644 hospitalized, 10,018 received it and 240 died of it; In France, out of 99,997, 15,600 received it and 199 died; In no ItalyOut of 89,895 it was administered to 72,635 and 1,822 died (with a margin of 1,170–2,063). Turkey, of 21,417, they administered it to 15,656 and of these 95 died (range 92–128); And in the United States 888,037 they gave to 551,471 and 12,739 would have died (3,244- 15,570).

According to the researchers, these findings show that Fear of using drugs with a low level of evidence for managing future epidemics.